Obstructive Hypertrophic Cardiomyopathy (oHCM) research hub

Mavacamten Outcomes in Hypertrophic Cardiomyopathy (HCM) and the Associated Patient and Physician Experiences in the US

This study looks at how a medicine called mavacamten works for adults with a heart condition called obstructive hypertrophic cardiomyopathy (oHCM). It aims to understand patients' and doctors' experiences with this treatment in the US.